News for September, 2008

Vytorin, Zetia squeeze manufacturers

The cholesterol-fighting drugs and Vytorin, blockbuster drugs that once represented multi-billion dollar sales for Schering-Plough and , now seem to be squeezing the pharmaceutical giants.

Read the rest of this entry »

SEAS study may link Vytorin, cancer

Today in Munich, Germany, researchers presented all of the data from the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study to the European Society of Cardiology. The SEAS study roused concern back in July when researchers revealed a possible link between and the half of Vytorin.

Read the rest of this entry »